NCT06385873 2024-05-13RC48 Combined With Adebrelimab, Apatinib and S-1 as Neoadjuvant Therapy in Locally Advanced Gastric CancerThe First Affiliated Hospital with Nanjing Medical UniversityPhase 2 Not yet recruiting32 enrolled